Did you know that your browser is out of date?
For the best experience we recommend upgrading to the latest version of these supported browsers:
I wish to continue viewing on my unsupported browser
Update: COVID-19 Vaccines, Trials, and Spending
NERA Director Dr. Chris Stomberg outlines the current status of COVID-19 vaccines, trials, studies, and EUAs in the US in NERA’s COVID-19 Q1 2021 Update.
Grappling with the Once and (Perhaps) Future Argentine Electricity Market
NERA experts Veronica Irastorza, Dr. Jeff D. Makholm, and Hamish Fraser outline a potential approach to the normalization of the electricity market in Argentina.
Virtual Marginal Cost Working Group Tackles Top Utility Sector Challenges
Join industry colleagues four our 3 March event to discuss experiences with regulatory successes and setbacks, test new ideas, and stay connected to major industry trends across North America and around the globe.
NERA Supports €140 Million Win in Pharma Arbitration
Managing Director Dr. Yves Hervé, along with Consultants Dr. Georg Siegert and Fabian Peters, provided economic analysis and expert testimony for an Austrian pharmaceutical company in its massive orphan drug case.
What Trends Will Affect Securities Class Actions in 2021?
Panelists from NERA, Skadden, Pomerantz, and Marsh presented the webinar “The State of Securities Class Actions: 2020 Trends and a Look Ahead” on 27 January.
NERA Turns 60
2021 marks six decades at the forefront of economic expertise. Happy anniversary, NERA!